Sebastien Miranda

JAK2 allelle burden and risk of venous thrombosis : our latest paper published in @ThrombosisRese1 Research from @UPJV_Univ @CHUAmiens with @SevestreMarie Pr Marolleau Dr Le Roy Dr Morel sciencedirect.com/science/articl…

New brief report: GDF-15 is strong predictor for #bleeding in patients with #Afib Mulder @amsterdamumc @MarcCarrier1 @MiddeldorpS et al find GDF-15 appeared to predict major bleeding in #cancer patients starting thromboprophylaxis. bit.ly/30Xj2R0

Nouveau DIU Pratique de la Recherche Clinique #PRatiC en 2021, pensez à vous inscrire ! @Univ_St_Etienne @UnivAngers @UBO_UnivBrest @PierreMarie2 @INNOVTE1 @FCouturaud @SFPT_fr @GIHP_official @cnet_therap inscriptions : florence.massart@univ-st-etienne.fr

@Yse_medvasc @afintmedvasc @lasfmv @Echoraljpangio @ClubVasculaire @cjurussfmv Attention Ce diagramme est très criticable !! On peut lire par exemple que avoir plus de 75 ans est une indication au tt par hbpm. Idem pour l insuffisance rénale. S'agit il d un retour en arrière de 15 ans ?

Symposium MTEV et cancer : une des conduites à tenir possible ! @lasfmv #sfmv2020 #medvasc @Echoraljpangio @afintmedvasc @ClubVasculaire @cjurussfmv

What personality type are you? #WearAMask

The rate of venous thrombosis post hospital discharge for #COVID19 is relatively low at 4.8 per 1000 discharges and in the absence of an RCT, routine post discharge thromboprophylaxis is not indicated. tinyurl.com/y56nwb7s #thrombosis #VTE

Patients with unprovoked #VTE are at higher risk of developing sub clinical or overt #atherosclerosis compared to healthy control @DellucAurelien @RodgerMarc sciencedirect.com/science/articl…

We have 2 new patient admitted for pe and dvt in the setting of previous covid infection discharched from the covid unit. So we have suggested to continue prophylactic dose of lmwh for 14 days for patient at very high risk (vte, cancer,obesity) what do you think about it?

High incidence of symptomatic thrombotic complications in COVID-19 patients at ICU? YES! We found 31% cumulative incidence despite routine thromboprophylaxis. Published today in @ThrombosisRese1: sciencedirect.com/science/articl…. #COVIDー19 #COVID19 @ErasmusMC @AmphiaZKHuis @LUMC_Leiden

Insightful editorial by Dr. @AggieLeeMD on the Caravaggio trial results comparing apixaban to LMWH in patients with cancer-associated thrombosis nejm.org/doi/full/10.10… @ThrombosisCan @canvector @cancerclot @ICTHICmagazine

Anticoagulant treatment with LMWH might be associated with decreased mortality in patients with severe #COVID19 with coagulopathy onlinelibrary.wiley.com/doi/10.1111/jt… @JTHjournal @isth

Très utile. A préciser aux patients lors de nos « consultations téléphoniques ».

Two studies describing lack of association between anticoagulation and TBI in older adults who fall, published in the same JAGS issue. Time to re-evaulate guidelines on with-holding anticoagulation in patients at risk of falls. onlinelibrary.wiley.com/doi/10.1111/jg…

Totally agree with that point of view. Treatment of APS should be adjusted to the risk of recurrence. We need more trials! Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance onlinelibrary.wiley.com/doi/full/10.10…

Very useful discussion about a frequent situation.

Notre article sur l’écho Doppler dans l’artérite à cellules géantes. A télécharger gratuitement pendant 50j !. #Horton #giantcellarteritis #ultrasound #medecineinternerouen authors.elsevier.com/a/1aTc8ubUqZo5A

Comparing outcomes following the perioperative interruptions of DOACs and VKAs among patients with atrial fibrillation. VKAs associated with increased major bleeding post-operatively. #atrialfibrillation #anticoagulation #DOACs @MarcCarrier1 @grelegal onlinelibrary.wiley.com/doi/full/10.10…

9% of 18-50yo patients with 1st unprovoked VTE fulfilled APS criteria; 1.4% were triple positive. High enough to test? Can’t wait your opinion Twitters!